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The world population is growing older. Between 2010 and 2015, the global life expectancy
has risen by 5.5 years, mainly due to improvements in child survival rates in developing
regions. Today, the global average life expectancy is ∼74 years for women and ∼70 years for
men. In developed regions, the life expectancy for women and men approaches or exceeds 80
years [1].
In 2010 it was estimated that there were 524 million old adults (≥65 years). This number
is expected to triple by 2050 [2]. Considering that old age is the most important risk factor
for dementia, it is expected that by 2050 the number of older persons with dementia (PwD)
will triple to 150 million worldwide [3]. Dementia is a syndrome that is characterized by
progressive neurodegeneration that surpasses normal age-related decline. PwD progressively
lose cognitive and physical abilities [3,4] and become increasingly dependent upon formal
and informal care. Dementia may have various causes, and it must be noted that at least
50% of PwD show signs of multiple dementia pathologies [5]. Alzheimer’s Disease (AD)
accounts for 60-80% of all dementia cases [6]. AD is characterized by deposits of Amyloid β
(Aβ) plaques and neurofibrillary tangles. Vascular Dementia (VaD), i.e., dementia resulting
from extensive damage to brain blood vessels appears in ∼40% of PwD [6]. Dementia with
Lewy Bodies (LBD), characterized by neuronal abnormalities in Alpha-synuclein protein, is
recognized as the third most common cause for dementia, accounting for another >10% of
dementia cases [6].
It is estimated that 1/3 of dementia cases are attributable to a combination of nine modifi-
able risk factors: low education in early life; hypertension, obesity and hearing loss in midlife;
and smoking, depression, physical inactivity, social isolation and diabetes in later life [7]. The
most important biological risk factor for dementia (AD in particular) is the Apolipoprotein ε4
(ApoE4) allele. ApoE4 is directly linked to AD through impaired lipoprotein metabolism [8],
which is associated with immunoreactive accumulations of Aβ and tau pathology and sub-
sequent declines in neurocognitive health [9,10]. Compared with ApoE2 and/or E3 carriers,
ApoE4 heterozygotes are three times more likely to develop AD and ApoE4 homozygotes are
eight times more likely to develop AD [9].
The economic burden of dementia is high. Costs for prevention, diagnosis, symptom
treatment, informal care and environmental adaptations for PwD increasingly accumulate
with time. In 2018, the global cost of dementia exceeded $1 trillion [3]. Considering the
high societal and economic burden of dementia it is of great importance that treatments are
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developed. Pharmacological treatments are still insufficient in producing clinically relevant
effects [11] and frequently cause side effects such as gastrointestinal issues and vertigo
[12]. Non-pharmacological treatments for dementia may pose fewer side-effects and include
exercise, music therapy, cognitive stimulation, social stimulation and sensory enrichment.
Amongst these, exercise may be the preferred choice as it is consistently associated with
better physical and mental health outcomes in older populations [13] conform the philosophy
’Exercise is medicine’.
Physical activity in old adults with and without dementia
The American College of Sports Medicine (ACSM) defines physical activity (PA) as ‘any
bodilymovement produced by skeletal muscles that results in energy expenditure above resting
levels’ [14]. Exercise is defined as ‘PA that is planned, structured, and repetitive and that has
as a final or intermediate objective the improvement or maintenance of physical fitness’. In
other words, exercise is PA that is specifically intended to improve fitness.
The WHO [13] advises all old adults to perform ≥150 minutes of moderate-intensity
aerobic PA and/or ≥75 minutes of vigorous-intensity aerobic PA, in bouts of ≥10 minutes,
every week. Whole-body muscle strengthening exercises should be done at least two days
per week. Especially old adults with mobility impairments are advised to perform balance
exercises on ≥3 days of the week. For old adults with poor physical health, even low amounts
of PA are beneficial. However, a review of PA levels in old adults from six continents
reported that only 20-60% of old adults met the recommended amounts of PA [15]. PwD
are even less active as compared to their healthy peers. Van Alphen and colleagues [16]
showed that community-dwelling PwD are ∼22% less active than cognitively healthy peers.
Institutionalized PwD even spend ∼72% of their day sitting. Low levels of PA are associated
with poor health, increased risk ofmortality and hospitalization and increased risk of cognitive
impairment [17]. Increasing PA may ameliorate poor health in PwD.
Exercise and functional outcomes in old adults with and without dementia
In healthy old adults, aerobic and strength exercise are associated with improvements in
physical function such as endurance, mobility, gait speed, muscle strength and balance [18-
21]. Multimodal exercise, i.e., a combination of aerobic, strength, and coordination training
has the highest efficacy for physical function. Likewise, the beneficial effects of exercise on the
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aforementioned physical functions are apparent in PwD with multimodal exercise having the
highest efficacy (see [22] for a review). Furthermore, multimodal exercise may be preferable
over aerobic-only exercise for Activities of Daily Life (ADL) in PwD [23].
Exercise-induced improvements in physical function may facilitate cognitive function
through increases in brain plasticity and activation [24-26]. In 1999, Arthur Kramer and
colleagues were among the first to show a positive effect of exercise on executive processes
in a sample of 124 healthy but sedentary old adults [27]. Since then there has been a growing
body of evidence that aerobic, anaerobic and multimodal exercise is related to better cognitive
function in healthy old adults, with multimodal exercise having the highest efficacy for
cognitive function (see [28] for a meta-analysis). In PwD, the effects of exercise on cognition
are inconclusive [29-33]. A combination of alternating aerobic and strength exercise appears
to be the most beneficial for physical and cognitive function [23,30] perhaps because 1)
aerobic exercise is facilitated through strength increases especially in the lower limbs and 2)
the neuromotor stimulus is higher in combined exercise compared with aerobic- only training
due to compensatory mechanisms. However, it is unknown whether such a combination is
also effective in PwD in earlier stages of dementia. Furthermore, it is unknown whether this
combination of alternating aerobic and strength training is effective when performed for a
longer period of time. Last, it is uncertain whether the beneficial effects of exercise in PwD
last after detraining.
Several underlying neurobiological mechanisms may play a role in the neuroprotective
effects of exercise. In animals and healthy old adults, exercise is related to dose-dependent in-
creases in growth factors (insulin-like growth factor type I (IGF1), brain derived neurotrophic
factor (BDNF), vascular endothelial growth factor (VEGF)), increases in neurotransmitters
(noradrenalin, serotonin, dopamine) and decreases in inflammatory markers (homocysteine
[34,35]). These neurobiological changes are related to changes in brain structure and con-
nectivity [36-39] in areas important for healthy cognitive function e.g. frontal and temporal
areas. Whether this is also true for PwD is yet to be determined by future studies. Figure 1
models the relationships between exercise and physical and cognitive function in PwD. This
model is adapted from Bossers [40].
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Figure 1. Relationships between exercise, physical function and cognition in PwD. Continu-
ous lines represent evidence-based relationships whereas dotted lines represent hypothesized
relationships.
Moderators and confounders of exercise effects on physical and cognitive function in
PwD
As previously outlined, the evidence for the efficacy of exercise for functional outcomes in
PwD is inconclusive. Furthermore, there is insufficient evidence to determine the variables
that may act as moderators and confounders of exercise effects on physical and cognitive
function in PwD. Such data are needed to optimize exercise programs for PwD and implement
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exercise efficiently in daily health care. Previous reviews and meta-analyses in healthy old
adults have identified several potential moderators and confounders. The effects of exercise
on executive processes may be more pronounced in older women vs. men [41] and in older vs.
younger seniors [42]. In addition, the effects of exercise on cognitive function in old adults
may bemoderated by genes and dietary factors [43]. In PwD, the effects of exercise on physical
and cognitive function appear to be independent of sex, age and dementia subtype, although
it is uncertain whether the effects of exercise are moderated by disease severity [22,32,33,44].
There is little or inconclusive evidence on several other potential moderators and confounders
of exercise effects in PwD. Use of medications with anticholinergic and/or sedative properties
(‘inappropriate medications’) as measured by the Drug Burden Index (DBI) is associated
with lower physical and cognitive function in healthy old adults [45-48]. Whether this is true
also for PwD is unknown. Data on the associations between DBI and physical and cognitive
function in PwD is needed to determine whether the effects of exercise on physical and
cognitive function are potentially confounded by anticholinergic and sedative drug burden.
In addition to drug burden, exercise type and dose-parameters (program duration, session
duration, frequency and intensity) may moderate the magnitude of exercise effects on physical
and cognitive function in PwD. However, the dose-response relationships between exercise
with physical and cognitive function in PwD are poorly understood. Especially exercise
intensity may be an important moderator of exercise effects because higher exercise intensity
is associated with better physical fitness (i.e., VO2max) and health outcomes [49-52] that may
fuel exercise effects on physical and cognitive function. Studies in which exercise intensities
are compared among randomized PwD are needed to investigate exercise intensity as potential
moderator in PwD. No such studies have been performed thus far. Last, preliminary evidence
has identified ApoE4-carriership to be a potential moderator of exercise effects on functional
outcomes in old adults with and without dementia [43,53]. However, it is uncertain whether
ApoE4 carriers as compared to non-carriers show greater or fewer benefits from exercise
on physical and cognitive function [53-56]. Furthermore, there is a scarcity of randomized
studies that investigate the strength and direction of this hypothesized moderation in PwD
specifically.
The effects of exercise on physical and cognitive function in PwD and potential moderators
and confounders can only be adequately assessed with performance-based tests that are
feasible, valid and reliable in PwD. The reliability of six motor tests for endurance, gait speed,
balance, strength and functional mobility was previously found to be good to excellent in PwD,
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although the reliability was lower for lower-functioning individuals [57]. Unfortunately, apart
from global cognitive batteries, there is limited data on the psychometric properties of many
cognitive tests in PwD. Furthermore, cognitive tests that are frequently used in healthy old
adults may not be feasible, reliable and valid in PwD. This may be especially true for the
STROOP task. The STROOP task measures selective attention and inhibitory control [58].
The STROOP taskmay be difficult for PwDbecause PwDmay experience color confusion [59]
and difficulties with verbal communication [60]. Furthermore, PwD may find the STROOP
task instructions difficult to comprehend. The Flanker task could be a suitable non-verbal
alternative for the STROOP task in PwD. The Flanker task requires the ability to inhibit
nonrelevant competing responses to a nonverbal target stimulus [61]. The Flanker task may
be a suitable alternative to the STROOP task in PwD because the Flanker task does not rely
upon verbal responses and the use of colors. However, the psychometric properties of the
Flanker task in PwD are yet to be evaluated.
Objectives and outline of this thesis
Themain objective of this thesis is to examine the efficacy of alternating aerobic and lower-limb
strength exercise vs. control activities for physical and cognitive function in a sample of older
persons with mild-to-moderate all-cause dementia. The secondary objective of this thesis is
to examine potential moderators and confounders of exercise effects in PwD. In this thesis
we will focus on anticholinergic and sedative drug burden, exercise type, dose-parameters
(program duration, session duration, frequency and intensity) and ApoE4-carriership. The
last objective of this thesis is to examine the suitability of a Flanker task as a measure of
inhibitory control in PwD.
Chapter 2 describes the results of a cross-sectional analysis into the associations between
anticholinergic and sedative drug burden with physical and cognition function in 140 nursing
home PwD. Chapter 3 describes the results of a systematic review and meta-analysis into the
effects of exercise on cognitive function in old adults with and without cognitive impairments.
We investigated cognitive status (healthy vs. cognitively impaired), exercise type (aerobic vs.
anaerobic vs. multimodal vs. psychomotor) and dose-parameters (program duration, session
duration, frequency and intensity) as potential moderators of exercise effects on cognition.
Chapter 4 describes the feasibility and results of a 24-week randomized controlled trial (RCT)
in 69 PwD visiting daycare or residing in residential care facilities. The primary outcomes
were physical and cognitive functions measured with performance-based tests. We used a
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two-arm exercise vs. control design, with the exercises being performed at a low (weeks
1-12) vs. high (weeks 13-24) intensity to investigate exercise intensity as potential moderator
of exercise effects. ApoE4-status was determined post-intervention as potential moderator
of exercise effects. Chapter 5 describes the results of a pilot study into the psychometric
properties (feasibility, validity and tests-retest reliability) of a computerized Flanker task
in 22 PwD. Finally, Chapter 6 summarizes and discusses the main findings of this thesis.
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